Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467870 · ClinicalTrials.gov registry record · Phase 3
Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men
A Phase 3 study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 531
- Enrollment target
NCT00467870: Completed Phase 3 study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
NCT00467870 is a Phase 3 study that has completed, run by Endo USA Inc., a Keenova Therapeutics Company. The registered enrollment target is 531 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00467870, a Phase 3 study, has completed, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 531 participants
- Enrollment target
Study Summary
To evaluate the pharmacokinetics of TU 750 mg and TU 1000 mg via multiple measurements of serum total testosterone.
Interventions
- DRUG Testosterone Undecanoate 750 mg
- DRUG Testosterone Undecanoate 1000 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 531 participants |
| Start Date | 2006-03 |
| Est. Completion | 2009-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00467870
The ClinicalTrials.gov registry entry for NCT00467870 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 531 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endo USA Inc., a Keenova Therapeutics Company, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Testosterone Undecanoate 750 mg is the first listed.
NCT00467870 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00467870 about?
NCT00467870 is a clinical study titled "Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men". To evaluate the pharmacokinetics of TU 750 mg and TU 1000 mg via multiple measurements of serum total testosterone.
What is the current status of trial NCT00467870?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 531 participants. The study started on 2006-03. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00467870?
The interventions under investigation include: Testosterone Undecanoate 750 mg (DRUG), Testosterone Undecanoate 1000 mg (DRUG).
Who is sponsoring clinical trial NCT00467870?
This trial is sponsored by Endo USA Inc., a Keenova Therapeutics Company, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.